RhumbLine Advisers’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.49M Sell
454,350
-20,136
-4% -$288K 0.01% 1278
2025
Q1
$4.98M Sell
474,486
-6,952
-1% -$73K ﹤0.01% 1359
2024
Q4
$5.83M Buy
481,438
+2,209
+0.5% +$26.8K 0.01% 1342
2024
Q3
$7.04M Sell
479,229
-1,840
-0.4% -$27K 0.01% 1239
2024
Q2
$6.94M Sell
481,069
-15,127
-3% -$218K 0.01% 1213
2024
Q1
$8.08M Sell
496,196
-68,574
-12% -$1.12M 0.01% 1154
2023
Q4
$8.42M Buy
564,770
+2,560
+0.5% +$38.1K 0.01% 1143
2023
Q3
$6.32M Sell
562,210
-1,406
-0.2% -$15.8K 0.01% 1220
2023
Q2
$5.67M Buy
563,616
+82,840
+17% +$833K 0.01% 1303
2023
Q1
$4.52M Sell
480,776
-9,375
-2% -$88.1K 0.01% 1388
2022
Q4
$5.99M Buy
490,151
+23,630
+5% +$289K 0.01% 1185
2022
Q3
$5.79M Buy
466,521
+23,563
+5% +$292K 0.01% 1143
2022
Q2
$8.7M Buy
442,958
+68,239
+18% +$1.34M 0.01% 962
2022
Q1
$9.78M Buy
374,719
+18,387
+5% +$480K 0.01% 960
2021
Q4
$10.1M Buy
356,332
+10,827
+3% +$307K 0.01% 976
2021
Q3
$11M Sell
345,505
-32,764
-9% -$1.04M 0.01% 903
2021
Q2
$13.1M Sell
378,269
-22,706
-6% -$788K 0.02% 847
2021
Q1
$11.8M Sell
400,975
-34,524
-8% -$1.02M 0.02% 886
2020
Q4
$13.4M Buy
435,499
+55,059
+14% +$1.69M 0.02% 758
2020
Q3
$10.6M Sell
380,440
-30,776
-7% -$860K 0.02% 739
2020
Q2
$8.82M Buy
411,216
+12,074
+3% +$259K 0.01% 847
2020
Q1
$8.94M Buy
399,142
+49,774
+14% +$1.11M 0.02% 708
2019
Q4
$10.3M Buy
349,368
+6,238
+2% +$184K 0.02% 817
2019
Q3
$9.12M Buy
343,130
+10,440
+3% +$278K 0.02% 819
2019
Q2
$11.2M Buy
332,690
+37,389
+13% +$1.26M 0.02% 717
2019
Q1
$9.47M Buy
295,301
+226,516
+329% +$7.26M 0.02% 783
2018
Q4
$2.17M Buy
+68,785
New +$2.17M ﹤0.01% 1595